Metformin combined with dipeptidyl peptidase-4 inhibitors or metformin combined with sulfonylureas in patients with type 2 diabetes: A real world analysis of the South Korean national cohort

Metabolism ◽

10.1016/j.metabol.2018.03.009 ◽

2018 ◽

Vol 85 ◽

pp. 14-22 ◽

Cited By ~ 1

Author(s):

Yeon Young Cho ◽

Sung-Il Cho

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Dipeptidyl Peptidase ◽

The South ◽

Dipeptidyl Peptidase 4 ◽

South Korean ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

National Cohort

Download Full-text

Differences in Cardiovascular and Renal Outcomes Between Sodium Glucose Co-Transporter-2 and Dipeptidyl Peptidase-4 Inhibitors Among Type 2 Diabetes Patients: A Real-World, Retrospective Cohort Study

SSRN Electronic Journal ◽

10.2139/ssrn.3759705 ◽

2021 ◽

Author(s):

Iskandar Idris ◽

Ruiqi Zhang ◽

Jil Billy Mamza ◽

Mike Ford ◽

Tamsin Morris ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Real World ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Renal Outcomes ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany—A retrospective analysis of real-world data

Osteoporosis International ◽

10.1007/s00198-017-4051-y ◽

2017 ◽

Vol 28 (8) ◽

pp. 2421-2428 ◽

Cited By ~ 32

Author(s):

S. Dombrowski ◽

K. Kostev ◽

L. Jacob

Keyword(s):

Type 2 Diabetes ◽

Retrospective Analysis ◽

Real World ◽

Bone Fracture ◽

Dipeptidyl Peptidase ◽

Real World Data ◽

World Data ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Real-world evaluation of glycemic control among patients with type 2 diabetes mellitus treated with canagliflozin versus dipeptidyl peptidase-4 inhibitors

Current Medical Research and Opinion ◽

10.1185/03007995.2016.1159954 ◽

2016 ◽

Vol 32 (6) ◽

pp. 1087-1096 ◽

Cited By ~ 17

Author(s):

Sarah Thayer ◽

Wing Chow ◽

Stephanie Korrer ◽

Richard Aguilar

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Glycemic Control ◽

Real World ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Evaluation of Dipeptidyl Peptidase-4 Inhibitors versus Thiazolidinediones or Insulin in Patients with Type 2 Diabetes Uncontrolled with Metformin and a Sulfonylurea in a Real-World Setting

The Permanente Journal ◽

10.7812/tpp19.224 ◽

2020 ◽

Vol 24 (5) ◽

Author(s):

Natalie Aboubechara

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Real World Setting ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Real-world adherence, persistence, and in-class switching during use of dipeptidyl peptidase-4 inhibitors: a systematic review and meta-analysis involving 594,138 patients with type 2 diabetes

Acta Diabetologica ◽

10.1007/s00592-020-01590-w ◽

2020 ◽

Author(s):

Oyepeju Ogundipe ◽

Mohsen Mazidi ◽

Ken Lee Chin ◽

Deval Gor ◽

Andrew McGovern ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Real World ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Class Switching ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Comparison of cardiovascular and renal outcomes between sodium glucose co– transporter–2 and dipeptidyl peptidase–4 inhibitors among type 2 diabetes patients: a real–world, retrospective cohort study

Metabolism ◽

10.1016/j.metabol.2020.154606 ◽

2021 ◽

Vol 116 ◽

pp. 154606

Author(s):

Iskandar Idris ◽

Ruiqi Zhang ◽

Jil Billy Mamza ◽

Mike Ford ◽

Tamsin Morris ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Real World ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Renal Outcomes ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Comprehensive efficacy of ipragliflozin on various conditioned type 2 diabetes compared with dipeptidyl peptidase-4 inhibitors and with both agents, based on a real-world multicenter trial

Diabetology International ◽

10.1007/s13340-021-00492-8 ◽

2021 ◽

Author(s):

Fumio Sawano ◽

Nozomu Kamei ◽

Mitsue Miyahara ◽

Kyoko Kobuke ◽

Shuhei Nakanishi ◽

...

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Dipeptidyl Peptidase ◽

Multicenter Trial ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

2209-PUB: Factors Associated with Switching from Sulfonylureas (SUs) to Dipeptidyl Peptidase-4 Inhibitors (DPP-4i) among Individuals with Type 2 Diabetes in the United States

Diabetes ◽

10.2337/db20-2209-pub ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 2209-PUB

Author(s):

XI TAN ◽

LINGFENG YANG ◽

KAMLESH KHUNTI ◽

RUYA ZHANG ◽

DIANA ZHANG ◽

...

Keyword(s):

United States ◽

Type 2 Diabetes ◽

The United States ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Factors Associated ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Mechanisms of Neurodegeration in Type 2 Diabetes and the Neuroprotective Potential of Dipeptidyl Peptidase 4 Inhibitors

Current Medicinal Chemistry ◽

10.2174/0929867322666150227153308 ◽

2015 ◽

Vol 22 (13) ◽

pp. 1573-1581 ◽

Cited By ~ 21

Author(s):

E. Matteucci ◽

O. Giampietro

Keyword(s):

Type 2 Diabetes ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Dipeptidyl peptidase-4 inhibitors and the risk of bullous pemphigoid among patients with type 2 diabetes

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2019.06.205 ◽

2019 ◽

Vol 81 (4) ◽

pp. AB47

Keyword(s):

Type 2 Diabetes ◽

Bullous Pemphigoid ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text